255 related articles for article (PubMed ID: 28583846)
1. Epigenetic effects of inhibition of heat shock protein 90 (HSP90) in human pancreatic and colon cancer.
Nagaraju GP; Wu C; Merchant N; Chen Z; Lesinski GB; El-Rayes BF
Cancer Lett; 2017 Aug; 402():110-116. PubMed ID: 28583846
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.
Nagaraju GP; Mezina A; Shaib WL; Landry J; El-Rayes BF
Eur J Cancer; 2016 Jan; 52():109-19. PubMed ID: 26682870
[TBL] [Abstract][Full Text] [Related]
3. Novel synthetic curcumin analogues EF31 and UBS109 are potent DNA hypomethylating agents in pancreatic cancer.
Nagaraju GP; Zhu S; Wen J; Farris AB; Adsay VN; Diaz R; Snyder JP; Mamoru S; El-Rayes BF
Cancer Lett; 2013 Dec; 341(2):195-203. PubMed ID: 23933177
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of HSP90 overcomes resistance to chemotherapy and radiotherapy in pancreatic cancer.
Nagaraju GP; Zakka KM; Landry JC; Shaib WL; Lesinski GB; El-Rayes BF
Int J Cancer; 2019 Sep; 145(6):1529-1537. PubMed ID: 30801702
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3.
Nagaraju GP; Park W; Wen J; Mahaseth H; Landry J; Farris AB; Willingham F; Sullivan PS; Proia DA; El-Hariry I; Taliaferro-Smith L; Diaz R; El-Rayes BF
Angiogenesis; 2013 Oct; 16(4):903-17. PubMed ID: 23838996
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation status of hMLH1, p16(INK4a), and CDH1 is not associated with mRNA expression levels of DNA methyltransferase and DNA demethylase in gastric carcinomas.
Oue N; Kuraoka K; Kuniyasu H; Yokozaki H; Wakikawa A; Matsusaki K; Yasui W
Oncol Rep; 2001; 8(5):1085-9. PubMed ID: 11496321
[TBL] [Abstract][Full Text] [Related]
7. HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to the effect of 5FU-based chemotherapy.
Nagaraju GP; Alese OB; Landry J; Diaz R; El-Rayes BF
Oncotarget; 2014 Oct; 5(20):9980-91. PubMed ID: 25296971
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein 90 (HSP90) is overexpressed in p16-negative oropharyngeal squamous cell carcinoma, and its inhibition in vitro potentiates the effects of chemoradiation.
Patel K; Wen J; Magliocca K; Muller S; Liu Y; Chen ZG; Saba N; Diaz R
Cancer Chemother Pharmacol; 2014 Nov; 74(5):1015-22. PubMed ID: 25205430
[TBL] [Abstract][Full Text] [Related]
9. Involvement of epigenetics and microRNA-29b in the urethane induced inception and establishment of mouse lung tumors.
Pandey M; Sultana S; Gupta KP
Exp Mol Pathol; 2014 Feb; 96(1):61-70. PubMed ID: 24361357
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines.
Azizi M; Teimoori-Toolabi L; Arzanani MK; Azadmanesh K; Fard-Esfahani P; Zeinali S
Cancer Biol Ther; 2014 Apr; 15(4):419-27. PubMed ID: 24448385
[TBL] [Abstract][Full Text] [Related]
11. The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer.
He S; Smith DL; Sequeira M; Sang J; Bates RC; Proia DA
Invest New Drugs; 2014 Aug; 32(4):577-86. PubMed ID: 24682747
[TBL] [Abstract][Full Text] [Related]
12. Hinokitiol induces DNA demethylation via DNMT1 and UHRF1 inhibition in colon cancer cells.
Seo JS; Choi YH; Moon JW; Kim HS; Park SH
BMC Cell Biol; 2017 Feb; 18(1):14. PubMed ID: 28241740
[TBL] [Abstract][Full Text] [Related]
13. Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition.
Hackl C; Lang SA; Moser C; Mori A; Fichtner-Feigl S; Hellerbrand C; Dietmeier W; Schlitt HJ; Geissler EK; Stoeltzing O
BMC Cancer; 2010 Dec; 10():668. PubMed ID: 21129190
[TBL] [Abstract][Full Text] [Related]
14. Targeting heat-shock protein 90 with ganetespib for molecularly targeted therapy of gastric cancer.
Liu H; Lu J; Hua Y; Zhang P; Liang Z; Ruan L; Lian C; Shi H; Chen K; Tu Z
Cell Death Dis; 2015 Jan; 6(1):e1595. PubMed ID: 25590805
[TBL] [Abstract][Full Text] [Related]
15. DNMT1 and DNMT3B modulate distinct polycomb-mediated histone modifications in colon cancer.
Jin B; Yao B; Li JL; Fields CR; Delmas AL; Liu C; Robertson KD
Cancer Res; 2009 Sep; 69(18):7412-21. PubMed ID: 19723660
[TBL] [Abstract][Full Text] [Related]
16. Effects of ginsenoside Rg3 on epigenetic modification in ovarian cancer cells.
Zhao L; Shou H; Chen L; Gao W; Fang C; Zhang P
Oncol Rep; 2019 Jun; 41(6):3209-3218. PubMed ID: 31002353
[TBL] [Abstract][Full Text] [Related]
17. Ganetespib, a unique triazolone-containing Hsp90 inhibitor, exhibits potent antitumor activity and a superior safety profile for cancer therapy.
Ying W; Du Z; Sun L; Foley KP; Proia DA; Blackman RK; Zhou D; Inoue T; Tatsuta N; Sang J; Ye S; Acquaviva J; Ogawa LS; Wada Y; Barsoum J; Koya K
Mol Cancer Ther; 2012 Feb; 11(2):475-84. PubMed ID: 22144665
[TBL] [Abstract][Full Text] [Related]
18. Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes.
Friedland JC; Smith DL; Sang J; Acquaviva J; He S; Zhang C; Proia DA
Invest New Drugs; 2014 Feb; 32(1):14-24. PubMed ID: 23686707
[TBL] [Abstract][Full Text] [Related]
19. miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1.
Chen Z; Liu S; Tian L; Wu M; Ai F; Tang W; Zhao L; Ding J; Zhang L; Tang A
Oncotarget; 2015 Nov; 6(35):38139-50. PubMed ID: 26497367
[TBL] [Abstract][Full Text] [Related]
20. HSP90 inhibition downregulates DNA replication and repair genes via E2F1 repression.
Liu H; Lu Z; Shi X; Liu L; Zhang P; Golemis EA; Tu Z
J Biol Chem; 2021 Aug; 297(2):100996. PubMed ID: 34302809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
